Microsoft AI CEO Mustafa Suleyman talks to Yahoo Finance about a new diagnostic breakthrough, the future of medical AI, and ...

Microsoft Corporation (NASDAQ:MSFT) is one of the high profit margin stocks to buy now. On June 30, Microsoft announced an ...

Despite the strong performance of Microsoft’s medical AI MAI-DxO in testing, which included models from OpenAI, Google, ...

Microsoft AI CEO Mustafa Suleyman says that the AI tool is one step closer to providing high-quality medical advice for ...

The AI system correctly solved 85.5% of medical cases in the study, outperforming 21 experienced doctors who averaged 20% ...

The tech giant poached several top Google researchers to help build a powerful AI tool that can diagnose patients and ...

Research is first initiative from Big Tech group’s AI health unit formed by ex-DeepMind co-founder Mustafa Suleyman ...

In the real world, ordering medical tests costs money, so Microsoft tracked the tests that the AI system and human doctors ...

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

Mustafa Suleyman. Put simply, to pass the Modern Turing Test, an AI would have to successfully act on this instruction: “Go make $1 million on a retail web platform in a few months with just a ...

Mustafa Suleyman has played a pivotal role in the evolution of AI, as co-founder of DeepMind and now as CEO of Microsoft AI. This hour, he reflects on his career and shares his vision for the future.

Mustafa Suleyman, the Co-Founder & Head of Applied AI, which Google acquired in 2014, took the stage at our Disrupt London event today to talk to our Special Projects Editor Jordan Crook about his ...